Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age
Moreira Junior, Edson Duarte; Giuliano, A R; Hoon, J de; Iversen, O-E; Joura, E A; Restrepo, J; Van Damme, P; Vandermeulen, C; Ellison, M C; Krick, A; Shields, C; Heiles, B; Luxembourg, Alain (Taylor & Francis, 2018)
